Shares of Concord Medical Services Holdings Limited (NYSE:CCM – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.13 and traded as high as $5.03. Concord Medical Services shares last traded at $4.8640, with a volume of 62,855 shares.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a report on Tuesday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on CCM
Concord Medical Services Price Performance
Concord Medical Services (NYSE:CCM – Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The company reported ($1.08) earnings per share for the quarter.
About Concord Medical Services
Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.
Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.
Read More
- Five stocks we like better than Concord Medical Services
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.
